Government of Korea
Also known as: Funded by Korea Disease Control and Prevent Agency | Gwanak-gu, Seoul, South Korea, 08779 | Korea Hydro & Nuclear Power | Korean Center for Disease Control and Prevention | Ministry for Food, Agriculture, Forestry and Fisheries, Korea | Ministry for Health, Welfare and Family Affairs of the Republic of Korea | Ministry of Education, Republic of Korea (2012R1A1A3A04002680) | Ministry of Education Science and Technology, Korea | Ministry of Food and Drug Safety, Korea | Ministry of Health, Republic of Korea | Ministry of Health & Welfare, Korea | Ministry of health & welfare, Republic of Korea | Ministry of Knowledge Economy, Korea | Ministry of Science and ICT | Ministry of Science and ICT, Korea | Ministry of Trade, Industry & Energy, Republic of Korea | National Institute of Food and Drug Safety Evaluation (Republic of Korea) | National Institute of Health, Korea | NCC,Korea | Rural Development Administration, Korea | The Korean Vascular Research Working Group | Veterans Health Service Medical Center, Seoul, Korea
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2005Last known activity
Sep 23, 2022
Timeline
1940s
- Aug 15, 1945
Government of Korea— Founded
Drugs by trial phase (112 distinct, 56 trials)
Phase 4 (17 own, 0 via acquisition)
Phase 3 (28 own, 0 via acquisition)
Phase 2 (45 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Indications
Studied for
- Anemia, Aplastic
- Anthrax
- Benign Paroxysmal Positional Vertigo
- Bursitis
- Cerebral Palsy
- Communicable Diseases
- Depression
- Depressive Disorder
- Diabetic Neuropathies
- Disease
- Dizziness
- Glomerulonephritis
- Glomerulonephritis, IGA
- Helicobacter Infections
- Hypertension
- Infections
- Influenza, Human
- Ischemia
- Kidney Diseases
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Myeloid
- Major Depressive Disorder
- Mental Disorders
- Neoplasms
- Nerve Degeneration
- Neuralgia
- Neuralgia, Postherpetic
- Neuroblastoma
- Parkinsonian Disorders
- Peripheral Nervous System Diseases
- Polyneuropathies
- Premature Birth
- Proteinuria
- Recurrence
- REM Sleep Behavior Disorder
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Rotator Cuff Injuries
- Schizophrenia
- Stomach Neoplasms
- Stroke
- Tuberculosis
- Tuberculosis, Multidrug-Resistant
- Tuberculosis, Pulmonary
- Vertigo
Recent trials (50)
- NCT05552495Overall official - principal investigatorPhase 1Sep 23, 2022
- NCT05287321CollaboratorPhase 3Apr 15, 2022
- NCT05175950CollaboratorPhase 2Jan 31, 2022
- NCT04945954CollaboratorN/AJun 30, 2021
- NCT04868786CollaboratorPhase 1Oct 26, 2020
- NCT04485156CollaboratorPhase 3Sep 30, 2020
- NCT04937634CollaboratorPhase 1Sep 11, 2020
- NCT04347486CollaboratorPhase 2May 1, 2020
- NCT04835883CollaboratorPhase 2Sep 26, 2019
- NCT04027829CollaboratorPhase 2Jul 15, 2019
- NCT03943888CollaboratorPhase 2Jul 10, 2019
- NCT03916198CollaboratorPhase 4Apr 30, 2019
- NCT03628131CollaboratorPhase 1/Phase 2Oct 31, 2018
- NCT03665402CollaboratorN/AMay 13, 2018
- NCT03306901CollaboratorN/AOct 20, 2017
Details
- Founded
- KR Aug 15, 1945
- Last known activity
- Sep 23, 2022